- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Respiratory Tripledemic 2022-23: Expert Update, Top Challenges
Distinguishing between influenza, COVID-19, and RSV and persuading vaccine-weary patients to get vaccinated are some of the challenges this season, says William Schaffner, MD.
"This has certainly been a distinctive season," said William Schaffner, MD, to Patient Care Online when asked about the current status of the 2022-2023 respiratory virus season.
This season is unique with the cocirculation of influenza, COVID-19, and respiratory syncytial virus (RSV). The "tripledemic," as it has been named, has brought challenges to clinicians caring for infected persons, such as diagnosing between the 3 respiratory diseases and persuading a vaccine weary population that they should get vaccinated, both with the influenza vaccine and the updated COVID-19 boosters. Below, Dr Schaffner gives a brief update on the current respiratory virus season and shares what his top challenges have been so far.
